Abstract
This research has a long-standing interest in understanding the basic mechanisms underlying epilepsy as well as in the development of improved therapeutic strategies. Here, we propose the development and characterization of a novel gene transfer approach. Specifically, the use of a defective (and harmless) viral vector to deliver the cDNA for an antiepileptic neuropeptide, neuropeptide Y …